Nobel laureate Elizabeth Blackburn has launched a company called Telome Health, and has created a commercial genetic test to measure telomere shortening, to give people insight on their aging process, reports Boonsri Dickinson at New Scientist. Blackburn says telomere length can give a patient a "sense of your underlying health," as researchers see telomere shortening in conditions like heart disease and cancer.